Hyperbaric oxygen therapy alleviates vascular dysfunction and amyloid burden in an Alzheimer’s disease mouse model and in elderly patients

Vascular dysfunction is entwined with aging and in the pathogenesis of Alzheimer’s disease (AD) and contributes to reduced cerebral blood flow (CBF) and consequently, hypoxia. Hyperbaric oxygen therapy (HBOT) is in clinical use for a wide range of medical conditions. In the current study, we exposed...

Descripción completa

Detalles Bibliográficos
Autores principales: Shapira, Ronit, Gdalyahu, Amos, Gottfried, Irit, Sasson, Efrat, Hadanny, Amir, Efrati, Shai, Blinder, Pablo, Ashery, Uri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457592/
https://www.ncbi.nlm.nih.gov/pubmed/34499614
http://dx.doi.org/10.18632/aging.203485

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457592/
https://www.ncbi.nlm.nih.gov/pubmed/34499614
http://dx.doi.org/10.18632/aging.203485

Ejemplares similares